drugset / Trial / NCT01635101

A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients

NCT01635101

Phase 3 Completed 197 enrolled Mallinckrodt
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to demonstrate the efficacy and safety of Intravenous (IV) acetaminophen plus rescue opioids for the relief of moderate to severe acute pain in neonates and infants (age \< 2 years) compared to placebo plus standard of care rescue opioids as well as characterize the concentration-effect relationship (PK/PD) of the intravenous acetaminophen as compared to the control group.

Timeline

Start
2012-06
Primary completion
2015-08
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 12.5 mg/kg Intravenous
Subject Acetaminophen Small molecule 15 mg/kg Intravenous

Indications

No indication recorded.